Funded Tech Companies

Vyriad

Operating out of Rochester, Vyriad has funding from Mayo Medical Ventures, Regeneron Pharmaceuticals and Mirae Asset Venture Investment.

Company Overview

Company Name
Vyriad
Company Status
Private & Independent
Funding Rounds

Contact Information

Mailing Address
2900 37th St. NW Building 110
Rochester, MN 55901
USA
Email Address

Company Background Information

Overview
Vyriad is a clinical-stage company developing proprietary oncolytic virus therapies for the treatment of cancers with significant unmet needs. The potentially life-changing oncolytic viral technologies of Vyriad are the result of decades of research by dedicated researchers and clinicians at Mayo Clinic and the University of Miami.
Profile
Vyriad LinkedIn Company Profile
Social Media
Vyriad Company Twitter Account
Company News
Vyriad News
Facebook
Vyriad on Facebook
YouTube
Vyriad on YouTube
Last Transaction
5/18/2022

Financing History

Date
Type
Amount
Venture Equity
$29,500,000


Management Team

Title
Name
Email & Social
Chief Executive Officer
Stephen Russell
  Stephen Russell LinkedIn Profile  Stephen Russell Twitter Account  Stephen Russell News  Stephen Russell on Facebook
Chief Financial Officer
Jim Hannon
  Jim Hannon LinkedIn Profile  Jim Hannon Twitter Account  Jim Hannon News  Jim Hannon on Facebook
Chief Medical Officer
Alice Bexon
  Alice Bexon LinkedIn Profile  Alice Bexon Twitter Account  Alice Bexon News  Alice Bexon on Facebook
Chief Technical Officer
Kah-Whye Peng
  Kah-Whye Peng LinkedIn Profile  Kah-Whye Peng Twitter Account  Kah-Whye Peng News  Kah-Whye Peng on Facebook


Company Investors

  • Mayo Medical Ventures
  • Regeneron Pharmaceuticals
  • Mirae Asset Venture Investment
  • Private Investors (Harry Stine)

 

 

 

Browse more funded tech companies:

Vypr | Vyrty

 

Share this article

 


About Our VC Deals Database

This tech company profile is powered by VentureDeal.com, a market leader in private equity transaction data.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary